- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04698889
Effect of Ingestion of Human, Cow, and Modified-cow Milk, on Glucose and Hormone Responses in Humans. (PROLAT)
Study of the Effects of Ingestion of Natural Human, Natural Cow, and Modified-cow Milk, on Glucose, Amino Acids, Insulin, and Incretin Responses in Humans
Study Overview
Status
Conditions
Detailed Description
Objective: To determine plasma glucose, insulin, C-peptide, glucagon-like polypeptide-1 (GLP-1), glucose-inhibitory-polypeptide (GIP) and amino-acid responses, following administration of human and cow milk, either natural or with experimentally-modified casein and whey-protein content(s).
Design. Young healthy volunteers of both sexes will receive iso-lactose loads (0.36 g lactose / kg body weight) of: natural cow milk; natural human milk; and of cow milk with modified casein and whey protein contents. Blood samples will be frequently collected over 4 hours. Plasma glucose, amino acids, insulin and incretin concentrations will be measured.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 20-35 yrs
- Both sexes
- Healthy
- In post-absorptive state
- Hemoglobin Hb1c values within normal values.
- Previous regular, moderate physical activity
- Stable body weight and regular dietary habits.
Exclusion Criteria:
- Familial or personal history of diabetes.
- Altered fasting glucose and/ or impaired glucose tolerance.
- Any metabolic, hormonal, hepatic, renal, and cardiovascular disease.
- Current drug treatments
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Cow milk
Administration of natural cow whole milk
|
|
|
Active Comparator: Human milk
Administration of natural human milk
|
|
|
Active Comparator: Modified cow milk - low protein
Administration of modified cow milk at low protein content
|
|
|
Active Comparator: Modified cow milk - high protein
Administration of modified cow milk at high protein content
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Plasma insulin and c-peptide
Time Frame: 1 year
|
microunits and nanomoles
|
1 year
|
|
Plasma GIP: glucose-inhibitory polypeptide and GLP-1: glucagon-like-polypeptide-1
Time Frame: 1 year
|
picomol/L and picogram/mL
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Plasma Amino acids
Time Frame: 2 years
|
micromol/L
|
2 years
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Tessari Protocol 1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hormone
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Adult Growth Hormone DeficiencyFrance
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Adult Growth Hormone DeficiencyDenmark
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Adult Growth Hormone DeficiencyGermany
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Growth Hormone Deficiency in ChildrenIsrael, Denmark, Belgium, Spain, Macedonia, The Former Yugoslav Republic of, Turkey, United Kingdom, France, Slovenia, Czech Republic
-
Novo Nordisk A/SWithdrawnGrowth Hormone Disorder | Growth Hormone Deficiency in Children
-
Novo Nordisk A/SCompletedHealthy | Growth Hormone Disorder | Adult Growth Hormone DeficiencyUnited States
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Growth Hormone Deficiency in Children | Delivery SystemsGermany, Netherlands, Sweden
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Adult Growth Hormone DeficiencyGermany
-
Merck KGaA, Darmstadt, GermanyCompletedAdult Growth Hormone Deficiency
-
Teva Pharmaceutical Industries, Ltd.TerminatedGrowth Hormone-DeficiencyBelarus, Bulgaria, Georgia, Greece, Hungary, Israel, Poland, Romania, Russian Federation, Serbia, Spain, Turkey, Ukraine
Clinical Trials on natural cow
-
Mead Johnson NutritionBeijing Kangchen TechnologiesTerminated
-
Medical University of WarsawAusnutria Hyproca B.V.Not yet recruitingGastrointestinal Diseases | Infant Nutrition DisordersPoland
-
Shaheed Zulfiqar Ali Bhutto Medical UniversityCompletedRectal ProlapsePakistan
-
Imperial College London Diabetes CentreUnknownGlucose Tolerance | Insulin SensitivityUnited Arab Emirates
-
Cooperative University of ColombiaColgate PalmoliveCompleted
-
Monell Chemical Senses CenterChildren's Hospital of Philadelphia; University of Wisconsin, Madison; University...Completed
-
Sprim Advanced Life SciencesArtsana S.p.a.CompletedFeeding Behavior
-
University of KarachiCompleted
-
Tel-Aviv Sourasky Medical CenterUnknown
-
Kendal Nutricare LtdObvioHealthCompleted